PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030 PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030

Posted on by Raj Gaurav Rai

PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030 PIRAMAL PHARMA: CO HAS RECEIVED SBTI APPROVAL FOR ITS COMMITMENT TO REDUCE SCOPE 1 AND 2 GHG EMISSIONS BY 42% AND SCOPE 3 BY 25% BY FY 2030

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related Posts

*Primary market activities* IPO opening today Emcure Pharma Ltd (Main board) – Issue size 1952.03Cr Bansal Wire Industries Ltd (Main board) – Issue size 745CrListing today Vraj Iron and Steel Ltd (Main board) – Subscribed 126.36x Diensten Tech Ltd (NSE SME) – Subscribed 53.94x StockMarket #FinancialNews *Primary market activities* IPO opening today Emcure Pharma Ltd (Main board) – Issue size 1952.03Cr Bansal Wire Industries Ltd (Main board) – Issue size 745CrListing today Vraj Iron and Steel Ltd (Main board) – Subscribed 126.36x Diensten Tech Ltd (NSE SME) – Subscribed 53.94x StockMarket #FinancialNews

*Primary market activities*IPO opening todayEmcure Pharma Ltd (Main board) – Issue size 1952.03CrBansal Wire Industries Ltd (Main board) – Issue size 745Cr Listing todayVraj Iron […]